XEELOMMIQ Trademark

Trademark Overview

On Friday, September 28, 2012, a trademark application was filed for XEELOMMIQ with the United States Patent and Trademark Office. The USPTO has given the XEELOMMIQ trademark a serial number of 85740961. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 21, 2016. This trademark is owned by Bristol-Myers Squibb Company. The XEELOMMIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
xeelommiq

General Information

Serial Number85740961
Word MarkXEELOMMIQ
Filing DateFriday, September 28, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 21, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 20, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 3, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, November 21, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 21, 2016ABANDONMENT - NO USE STATEMENT FILED
Thursday, May 12, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 11, 2016EXTENSION 5 GRANTED
Monday, April 11, 2016EXTENSION 5 FILED
Monday, April 11, 2016TEAS EXTENSION RECEIVED
Tuesday, October 27, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 26, 2015EXTENSION 4 GRANTED
Thursday, October 15, 2015EXTENSION 4 FILED
Friday, October 23, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 15, 2015TEAS EXTENSION RECEIVED
Tuesday, April 7, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 6, 2015EXTENSION 3 GRANTED
Monday, March 23, 2015EXTENSION 3 FILED
Monday, March 23, 2015TEAS EXTENSION RECEIVED
Thursday, October 23, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 22, 2014EXTENSION 2 GRANTED
Wednesday, October 15, 2014EXTENSION 2 FILED
Wednesday, October 15, 2014TEAS EXTENSION RECEIVED
Tuesday, May 6, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 5, 2014EXTENSION 1 GRANTED
Tuesday, April 15, 2014EXTENSION 1 FILED
Friday, May 2, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 15, 2014TEAS EXTENSION RECEIVED
Tuesday, October 15, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 20, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 20, 2013PUBLISHED FOR OPPOSITION
Wednesday, July 31, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 12, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, July 12, 2013ASSIGNED TO LIE
Sunday, June 23, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 21, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, June 21, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 21, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 3, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 28, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 28, 2013NON-FINAL ACTION E-MAILED
Monday, January 28, 2013NON-FINAL ACTION WRITTEN
Monday, January 28, 2013ASSIGNED TO EXAMINER
Wednesday, October 3, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, October 2, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

xeelommiq diseases pharmaceutical human anti preparations disorders organ solid auto immune